Glass House Brands Inc.

GLAS Healthcare Drug Manufacturers Specialty & Generic

Glass House Brands Inc.’s revenue for fiscal 2025 (year ended December 2025) was $182.0 million, down 9.41% from fiscal 2024.

Revenue
−1.24%
EPS
−320.0%
Free cash flow
−123.4%
Total debt
−17.2%

Quarter to June 2026, against a year earlier

2.04 0.19 −8.52%
Market cap
$172.7M
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
3/9
Altman Z
1.38
Beneish M
−3.38
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+7 more quarters

P/S ratio
6.52 4.00 3.98 3.37
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
6,446.33 (60.48) (195.93) (122.60)
P/B ratio
15.89 8.37 8.83 6.95
Price to Tangible BV
16.09 9.70 8.92 8.01
EV/Sales
6.73 4.25 4.30 3.61
EV/EBITDA
0.00 0.00 0.00 49.28
EV/Operating CF
(58.57) (271.76) 68.29 28.46
EV/FCF
(32.37) (28.41) (50.40) (166.08)
Quick Ratio
0.55 0.79 0.46 1.03
Current Ratio
1.33 1.85 1.78 2.24
Net Debt/EBITDA
46.53 (4.29) (6.83) (5.93)
Debt/Assets
17.78% 21.12% 21.69% 21.91%
Debt/Equity
0.77 0.81 0.84 0.79
Asset Turnover
0.55 0.56 0.58 0.59
Operating CF/Net income
(0.02) 0.59 0.20 0.33
Capex/Depreciation
(0.56) (0.88) (0.54) (2.16)
Interest Coverage
(4.77) (11.08) (11.40) (6.26)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
29.23% 43.14% 46.76% 43.25%
Intangible Assets out of Total Assets
0.00 0.04 0.00 0.04
Share Based Compensation of Revenue
8.96% 11.16% 8.36% 10.61%
Graham Net Nets
(0.15) (0.23) (0.23) (0.25)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(5.85%) (7.35%) (6.21%) (2.93%)
Free Cash Flow Yield
(3.19%) (3.74%) (2.14%) (0.64%)
Revenue per Share
0.53 0.47 0.62 0.47
Operating CF per Share
0.00 (0.13) (0.05) (0.06)
Capex per Share
(0.02) (0.04) (0.03) (0.10)
Free Cash Flow per Share
(0.02) (0.18) (0.07) (0.17)
Cash per Share
0.21 0.28 0.15 0.32
Shareholders Equity per Share
0.82 0.98 1.00 1.08
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.82 0.98 1.00 1.08
Free Cash Flow
(1.93) (15.30) (5.88) (13.69)
Working Capital
17.85 34.15 29.79 41.11
Capital Expenditures
(2.11) (3.55) (2.18) (8.63)
Net Current Asset Value
(169.53) (166.05) (168.71) (156.22)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.04 0.09 0.04 0.22
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
10.80 7.92 6.17 5.99
Average Payables
37.79 34.39 29.69 27.85
Average Inventory
26.85 23.61 19.28 14.11
Average Assets
323.97 318.47 314.53 311.80
Average Common Equity
86.58 85.25 79.90 78.17

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026